Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

333.663
+7.0062.14%
Number of Gainers:31
Number of Losers:15
Number of Flat:16
PE:- -
High:340.951
Open:329.543
Low:328.790
Close:326.657
Volume:158.25M
Turnover:5.96B
Market Cap:799.69B
Float Cap:689.60B

Loading ...

XPeng CEO Foresees L4 and L5 Autonomous Driving Deployment Within 3-5 Years, Exceeding Expectations

Deep News
·
Yesterday

Angelalign Announces Extraordinary General Meeting

Reuters
·
Yesterday

Kindstar Global Executes Share Buyback, Spending HK$30,800 on July 2

Stock News
·
Yesterday

Kindstar Globalgene Files HKEX Next-day Return Disclosing Share Buyback

Reuters
·
Yesterday

BAIRONG-W Grants 3.1325 Million Share Awards

Stock News
·
Yesterday

Bairong Grants 3,132,500 Employee Share Awards Under 2024 Share Scheme

Reuters
·
Yesterday

Shareholders of Struggling NAYUKI Propose Founder's Salary Be Reduced to 1 Yuan

Deep News
·
Yesterday

Shareholder Confronts NAYUKI Over Executive Pay Amidst Years of Losses

Deep News
·
Yesterday

ZYLOXTB Executes Share Buyback, Spending HKD 282,800

Stock News
·
Yesterday

Zylox-tonbridge Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Yesterday

Hutchmed Gets China Nod for Gastric Cancer Drug Application

MT Newswires Live
·
Yesterday

XPENG-W Issues 43.6 Thousand Shares Under 2019 Equity Incentive Plan

Stock News
·
Yesterday

CHAOJU EYE CARE Executes Share Repurchase, Spending Approximately HKD 71,300

Stock News
·
Yesterday

Chaoju Eye Care Files HKEX Next-day Return Disclosing Share Repurchase for Cancellation

Reuters
·
Yesterday

HUTCHMED's Savolitinib Gains Conditional NMPA Approval for MET-Amplified Gastric Cancer

Stock News
·
Yesterday

Hutchmed Says China Regulator Grants Conditional Approval for Orpathys in Met-amplified Gastric Cancer

Reuters
·
Yesterday

Hutchmed Announces Nmpa Approval for Orpathys® for the Treatment of Gastric Cancer Patients with Met Amplification

THOMSON REUTERS
·
Yesterday

HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification

GlobeNewswire
·
Yesterday

Global Market Share of ChatGPT Declines for the First Time; Chinese Large Models Showcase Open-Source and Cost Advantages, Boosting Stocks of Alibaba, Tencent, and Baidu

Deep News
·
Yesterday

Management Faces Tough Questions at NAYUKI Shareholder Meeting, Denies Market Cap Management Plans and Defends Pre-made Bread

Deep News
·
Yesterday